News from arena pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:ARNA)

Jan 12, 2016, 16:05 ET

Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia

Boehringer Ingelheim and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that they have signed an exclusive agreement to conduct joint...

Jan 07, 2016, 08:00 ET

Arena Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at the...

Dec 01, 2015, 08:00 ET

Eisai and Arena Pharmaceuticals Announce Completion of Enrollment in BELVIQ® (lorcaserin HCl) CAMELLIA-TIMI 61 Study

Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that the CAMELLIA-TIMI 61 study has reached its target enrollment of...

Nov 30, 2015, 08:00 ET

Eisai and Arena Pharmaceuticals Announce FDA Acceptance of New Drug Application for Extended Release Formulation of Lorcaserin

Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing...

Nov 24, 2015, 08:00 ET

Arena Pharmaceuticals to Present at Piper Jaffray 27th Annual Healthcare Conference

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at the...

Nov 19, 2015, 08:00 ET

Arena Pharmaceuticals to Host Analyst & Investor Day on December 3rd

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company will host an Analyst & Investor Day on Thursday, December...

Nov 10, 2015, 16:00 ET

Arena Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported financial results for the third quarter ended September 30, 2015, and provided a...

Nov 04, 2015, 08:00 ET

Arena Pharmaceuticals to Host Third Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, November 10

 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it will host a conference call and webcast at 5:00 p.m. Eastern Time...

Nov 02, 2015, 08:00 ET

Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at 2015 Annual Obesity Week Meeting

 Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that six posters regarding lorcaserin HCl data will be presented...

Oct 29, 2015, 08:00 ET

Arena Pharmaceuticals Initiates a Phase 1b Clinical Trial of APD371

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the initiation of patient dosing in a Phase 1b multiple-ascending dose clinical trial of...

Oct 27, 2015, 16:00 ET

Arena Pharmaceuticals Announces New Strategic Focus and Cost Reduction Plan

 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced plans to improve efficiencies and reduce costs as it focuses on the advancement of...

Oct 27, 2015, 08:00 ET

Arena Pharmaceuticals Issued Additional Patent Covering BELVIQ® (lorcaserin HCl) by United States Patent and Trademark Office

 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that the US Patent and Trademark Office granted Arena US Patent No....

Oct 05, 2015, 16:15 ET

Arena Pharmaceuticals Announces Retirement of President and CEO

 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that, at the request of the Board of Directors, Jack Lief, Arena's President and...

Sep 24, 2015, 08:00 ET

Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings

 Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that lorcaserin HCl data will be presented at the following medical...

Sep 03, 2015, 08:00 ET

Arena Pharmaceuticals to Present at the Wells Fargo 2015 Healthcare Conference

 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at...

Aug 05, 2015, 16:01 ET

Arena Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update

 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported financial results for the second quarter ended June 30, 2015, and provided a...

Jul 30, 2015, 08:00 ET

Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5

 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it will host a conference call and webcast at 5:00 p.m. Eastern Time...

Jul 29, 2015, 08:00 ET

Arena Pharmaceuticals Initiates a Phase 2 Clinical Trial of APD334, its S1P1 Receptor Modulator for Autoimmune Diseases

 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the initiation of patient screening in a Phase 2 proof-of-concept clinical trial of...

Jun 16, 2015, 16:30 ET

Arena Pharmaceuticals Announces the Departure of Chief Financial Officer

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that Robert E. Hoffman, Senior Vice President, Finance and Chief Financial Officer, has...

Jun 04, 2015, 13:30 ET

Lorcaserin HCl Data to be Presented at American Diabetes Association's 75th Scientific Sessions

 Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the following poster regarding lorcaserin HCl will be...